NCT01355822View on ClinicalTrials.gov

Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

January 31, 2008

Conditions
High Risk Pregnancy
Interventions
DRUG

PETN

Pentaerythrithyltetranitrate: 80 mg orally twice a day

DRUG

Placebo control

orally, twice daily

Trial Locations (1)

07743

University Hospital Jena, Department of Obstetrics, Jena

All Listed Sponsors
lead

University of Jena

OTHER

NCT01355822 - Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies | Biotech Hunter | Biotech Hunter